Objective
does staged complete revascularisation with PCI for STEMI (non-culprit) reduce adverse events compared to PCI of culprit-lesion only in acute MI with MV-Disease
Study
multinational randomised trial
Population
STEMI patients with MV-Disease staged non-culprit lesion PCI performed either during or after index hospitalisation
Endpoints
first composite cardiovascular death or MI. Second composite cardiovascular death, MI or ischemia-driven revascularisation at median follow-up of 3 years
Conclusion
complete revascularisation (staged) PCI was superior to culprit-lesion only PCI in patients with STEMI and multivessel disease to reduce adverse events
Mehta et al. N Engl J Med. 2019;381:1411-21
